BridgeMD
New treatment option for Carpal Tunnel Syndrome
Official title High-Intensity Laser Therapy in Carpal Tunnel Syndrome: Clinical, Sonographic, and Electrophysiological Outcomes
ClinicalTrials.gov ID: NCT07414069
What this study is testing
- What it's testing
- Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy of the upper extremity and is characterized by pain, paresthesia, and functional impairment resulting from increased pressure within the carpal tunnel. Although conservative treatment approaches such as splinting and pharmacological therapy are commonly used, High-Intensity Laser Therapy (HILT) has emerged as a non-invasive modality with potential analgesic, anti-inflammatory, and biostimulatory effects.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Age between 18 and 65 years
- Clinical symptoms consistent with carpal tunnel syndrome
- Electrophysiologically confirmed mild or moderate carpal tunnel syndrome
- Ability to comply with the study protocol and follow-up assessments
- Provided written informed consent
You likely can't join if
- Severe carpal tunnel syndrome on electrophysiological examination
- Previous surgical treatment for carpal tunnel syndrome
- Local causes of carpal tunnel syndrome (e.g., mass lesions, ganglion cysts, tumors)
- Systemic conditions associated with carpal tunnel syndrome (e.g., diabetes mellitus, hypothyroidism, pregnancy, acromegaly)
- History of corticosteroid injection for carpal tunnel syndrome within the last 6 months
- Presence of polyneuropathy, radiculopathy, or other upper extremity peripheral nerve disorders
See the full eligibility criteria
- Age between 18 and 65 years
- Clinical symptoms consistent with carpal tunnel syndrome
- Electrophysiologically confirmed mild or moderate carpal tunnel syndrome
- Ability to comply with the study protocol and follow-up assessments
- Provided written informed consent
- Severe carpal tunnel syndrome on electrophysiological examination
- Previous surgical treatment for carpal tunnel syndrome
- Local causes of carpal tunnel syndrome (e.g., mass lesions, ganglion cysts, tumors)
- Systemic conditions associated with carpal tunnel syndrome (e.g., diabetes mellitus, hypothyroidism, pregnancy, acromegaly)
- History of corticosteroid injection for carpal tunnel syndrome within the last 6 months
- Presence of polyneuropathy, radiculopathy, or other upper extremity peripheral nerve disorders
- Contraindications to electrophysiological testing or laser therapy
- Inability to complete follow-up assessments
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Ankara, Çankaya, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Ankara, Çankaya, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.